Encouraging Young Scientists
Through the Fellowship Programme, ILCA supports research in all liver cancer related disciplines by encouraging young scientists to develop their career in liver cancer research.
ILCA Fellowship 2021: Apply Now!
We are thrilled to launch the 7th edition of the ILCA Fellowship Programme. If you are a young scientist eager to develop your career in liver cancer research, this opportunity is for you!
Applications for this 1-year programme will be submitted to the ILCA Office before 19 April 2021.
The awarded fellow will be recognized during the ILCA Annual Conference 2021.
Applications will be centralized by the ILCA Office and reviewed by the Executive Committee and Education Committee.
The outcome of the selection process will be made public early May.
ILCA Fellowship 2020 Awardee
Congratulations to the ILCA Fellowship 2020 Awardee!
ILCA is pleased to announce that Aveline Filliol, Postdoctoral Research Scientist from the Columbia University, USA, has been awarded the ILCA Fellowship 2020.
ILCA will support her research on “Deciphering the role of hepatic stellate cell-derived myofibroblasts in hepatocellular carcinoma”. Aveline Filliol will be working on determining the role of hepatic stellate cell-derived myofibroblasts in the development of hepatocellular carcinoma.
Discover a bit more about our ILCA Fellowship 2020 awardee
Through the Fellowship Programme, ILCA supports research in all liver cancer-related disciplines by encouraging young Scientifics to develop their career in liver cancer research. This year ILCA Fellowship Programme 2020 is supported by an Educational Grant from:
Stay tuned for future ILCA Fellowship Programmes available!
ILCA Fellowship 2019 Awardee
Congratulations to the ILCA Fellowship 2019 Awardee!
ILCA is pleased to announce that Dr. Jin Lee, from the Department of Pathology of the School of Medicine, University of California, San Diego, was awarded the ILCA Fellowship 2019.
ILCA will support her research on Immunotherapeutic Target on Unique Mitotic Spindle in Hepatocellular Carcinoma.
Can you please tell us a bit about your research project?
Despite microtubule-binding compound being widely used as a chemotherapeutic in the treatment of various cancers, it has shown disappointing results in liver cancer, since it extensively affects normal cells. Specifically targeting mitosis in cancer cells is considered as a preferred strategy. For this purpose, I am working on study to know whether immune cells can target specifically proliferating cancer cells through unique mitosis machinery and what mechanism they have.
For my objectives, I will successfully complete this project with a goal to discover a novel target of HCC and propose a new therapeutic strategy for treatment humans with HCC. I hope this work will contribute in clinic finally.
Why did you get involved in this type of research?
There is nothing nicer than knowing. My pleasure was to discover the undiscovered things and this led me to do basic science research. So far human beings have been suffering from many types of cancer. I believed in basic science is fundamentally essential to the study of the medicine and it is the key of the drug discovery especially for cancer. For this reason, I did get involved in cell biology research and want to know about how tumour cells communicate with other type of cells in tumour microenvironment.
How will the ILCA grant help you?
I am so grateful that ILCA will support my research. It is an honor to receive this prestigious fellowship. The ILCA grant will encourage me to pursue science and to increase self-motivation. It will be a milestone for the next chapter of my career as an independent scientist.
ILCA Fellowship 2018 Awardee
Congratulations to the ILCA Fellowship 2018 Awardee!
ILCA is pleased to announce that Dr. Stefanie Hectors, from the Icahn School of Medicine at Mount Sinai, was awarded the ILCA Fellowship 2018.
ILCA is supporting her research on Quantitative MRI for Noninvasive Prediction of Gene Signatures in Hepatocellular Carcinoma.